1-171205299-T-A
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The ENST00000209929.10(FMO2):c.848T>A(p.Val283Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,457,938 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
ENST00000209929.10 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
FMO2 | NM_001460.5 | c.848T>A | p.Val283Glu | missense_variant | 7/9 | ENST00000209929.10 | NP_001451.2 | |
LOC124900413 | XR_007066731.1 | n.366-8361A>T | intron_variant, non_coding_transcript_variant | |||||
LOC105371611 | XR_922278.4 | n.515-37111A>T | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
FMO2 | ENST00000209929.10 | c.848T>A | p.Val283Glu | missense_variant | 7/9 | 1 | NM_001460.5 | ENSP00000209929 | P1 | |
ENST00000445290.1 | n.139-5784A>T | intron_variant, non_coding_transcript_variant | 2 | |||||||
ENST00000669750.1 | n.449-37111A>T | intron_variant, non_coding_transcript_variant |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1457938Hom.: 0 Cov.: 30 AF XY: 0.00000138 AC XY: 1AN XY: 725554
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 18, 2022 | The c.848T>A (p.V283E) alteration is located in exon 7 (coding exon 6) of the FMO2 gene. This alteration results from a T to A substitution at nucleotide position 848, causing the valine (V) at amino acid position 283 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
No publications associated with this variant yet.